20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Press releases 

24 October 2008

•  Cancer vaccine shows promise in patients with bowel, kidney and prostate cancer

23 October 2008

•  Early trial of new multi-kinase inhibitor shows impressive activity in medullary thyroid cancer
• Study finds BRAF mutations in colorectal cancer cause resistance to anti-EGFR therapy

22 October 2008

• New way of inhibiting the cell cycle shows promise in cancer patients in a phase I clinical trial
• Researchers identify pattern of gene expression that can predict how patients with advanced bowel cancer will respond to treatment
• Crossing the blood-brain barrier: scientists develop a new drug delivery system for brain cancers and other, hard-to-treat diseases of the central nervous system
• Researchers discover the anti-cancer drug bevacizumab can be used to detect and diagnose tumours in animal models using PET/CT imaging: results are better than current ‘gold standard’ method

21 October 2008 

• Assessing the quality of phase I clinical trial abstracts submitted to the EORTC-NCI-AACR and ASCO meetings